We’re Facing Important Challenges Regarding the Affordability of Innovation in Care Delivery

FasterCures A Center of the Milken InstituteI was pleased to participate, in association with FasterCures, on a panel with several thoughtful people at the recent Milken Institute’s Global Conference.

Our panel titled If You Cure It, Will They Pay? Putting a Value on Lives explored important elements of this topic. You might be particularly interested in the comments from Gregg Alton of Gilead Sciences, the manufacturers of the new Hepatitis C drug, Solvadi, among the other esteemed panelists.

In addition to the video provided, I think you will also enjoy highlights noted in the session summary on the FasterCures blog.